Earnings Call Insights: Runway Growth Finance Corp. (RWAY) Q1 2026 Management View Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Du
Lyft forecasts accelerated revenue and profitability expansion following strong demand and integration of Gett U.K. Lyft expects approximately 20% year-over-year growth in gross bookings and over 30% expansion in adjusted EBITDA for Q1 2026. The outlook follows a quarter o
Stoke Therapeutics targets Q1 2027 for rolling NDA submission, backed by $411M cash, with Phase III enrollment slated for June. Stoke Therapeutics announced plans to initiate a rolling New Drug Application (NDA) in Q1 2027, supported by a $411M cash balance. The company ai
Ready Capital reports quarterly loss of $0.33 per share Ready Capital reported a quarterly loss of $0.33 per share. The loss missed the estimated loss of $0.13 per share. This compares to break-even earnings per share a year ago.
Crinetics Pharmaceuticals reports $10.3 million in Q1 2026 net product revenue and 232 new patient enrollments. Crinetics Pharmaceuticals raised its Palsonify coverage target to exceed 75% by the end of Q3 2026, citing strong operational momentum. The company reported $10.
Gevo forecasts $30M in 2026 adjusted EBITDA as it seeks financing for its Project North Star by year-end. Gevo expects to achieve approximately $30M in adjusted EBITDA for 2026, building on four consecutive quarters of positive non-GAAP adjusted EBITDA. The company aims to
BLFS forecasts 2026 revenue between $112.5M and $115M after Q1 growth of 25% and adjusted EBITDA up 15%. BioLife Solutions (BLFS) outlined a 2026 revenue target of $112.5M to $115M while aiming for full-year GAAP net income. The company reported a strong start to the year,
The company reports $17 million in new wins for Q1 2026 while maintaining a 17%-19% gross margin outlook. Core Molding Technologies announced plans to secure $50 million in new awards by 2026, following a strong start to the year. The company reported $17 million in additi
New CEO outlines strategic priorities as company raises fiscal 2026 free cash flow growth guidance to 22%-25%. OpenText raised its fiscal 2026 free cash flow growth target to 22%-25%, signaling confidence in its financial outlook. The company also increased its cloud reven
Cannabis firm Trulieve forecasts at least $250M in 2026 operating cash flow as U.S. policy shifts fuel uplisting prospects. Trulieve Cannabis Corp. expects to generate at least $250M in operating cash flow by 2026, driven by recent U.S. regulatory moves. The company cited
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.